Mechanisms Involved in Microglial-Interceded Alzheimer’s Disease and Nanocarrier-Based Treatment Approaches
Alzheimer’s disease (AD) is a common neurodegenerative disorder accountable for dementia and cognitive dysfunction. The etiology of AD is complex and multifactorial in origin. The formation and deposition of amyloid-beta (Aβ), hyperphosphorylated tau protein, neuroinflammation, persistent oxidative...
Guardado en:
Autores principales: | Shadab Md, Nabil A. Alhakamy, Mohamed A. Alfaleh, Obaid Afzal, Abdulmalik S. A. Altamimi, Ashif Iqubal, Rasheed A. Shaik |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bae06ef507ca49a3a848e5c0c78958b4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Liposomal Encapsulated Curcumin Effectively Attenuates Neuroinflammatory and Reactive Astrogliosis Reactions in Glia Cells and Organotypic Brain Slices
por: Schmitt C, et al.
Publicado: (2020) -
Sex-Specific Microglial Activation and SARS-CoV-2 Receptor Expression Induced by Chronic Unpredictable Stress
por: Ling Yan, et al.
Publicado: (2021) -
Polymeric Micro/Nanocarriers and Motors for Cargo Transport and Phototriggered Delivery
por: Pedro Mena-Giraldo, et al.
Publicado: (2021) -
Nanocarriers in the Enhancement of Therapeutic Efficacy of Natural Drugs
por: Xiuling Li, et al.
Publicado: (2021) -
Exosomes as Actively Targeted Nanocarriers for Cancer Therapy
por: Wang Y, et al.
Publicado: (2020)